阴虚型HBV相关原发性肝癌患者的肿瘤特征及淋巴细胞计数与生化指标的相关性分析

杨志云; 杜林林; 何玲玲; 赵亚林; 江宇泳; 李秀兰

doi:10.3969/j.issn.1001-5256.2016.03.023

阴虚型HBV相关原发性肝癌患者的肿瘤特征及淋巴细胞计数与生化指标的相关性分析

DOI: 10.3969/j.issn.1001-5256.2016.03.023

1. 首都医科大学附属北京地坛医院
2. 首都医科大学重大传染病防治协同创新中心

基金项目:

北京市自然科学基金(7142081)；首都中医药研究专项课题(14ZY05)；北京卫生系统高层次人才培养项目(2013-3-026)；

详细信息

中图分类号: R512.62;R735.7
计量
- 文章访问数: 2204
- HTML全文浏览量: 5
- PDF下载量: 417
- 被引次数: 0
出版历程
- 出版日期: 2016-03-20

Tumor features and correlation between lymphocyte count and biochemical parameters in patients with hepatitis B vi-rus- associated primary liver cancer with Yin deficiency

Beijing Ditan Hospital, Capital Medical University

Research funding:

摘要

摘要:
目的探讨阴虚型HBV相关原发性肝癌（PLC）患者的肿瘤特征及淋巴细胞计数与生化指标的相关性。方法收集2013年7月-2015年2月于首都医科大学附属北京地坛医院治疗的PLC患者148例,分为阴虚型PLC组（n=52）和非阴虚型PLC组（n=96）。收集患者的一般资料及实验室指标,包括肿瘤学指标[甲胎蛋白（AFP）、癌胚抗原（CEA）、糖类抗原（CA）19-9],病毒学指标（HBs Ag）,肿瘤大体分型（结节型、块状型、巨块型、弥漫型）,影像学特征（门静脉主干内径、门静脉癌栓、肝外转移）,生化指标[终末期肝病模型（MELD）评分、白细胞（WBC）、红细胞（RBC）、血小板（PLT）、ALT、AST、TBil、GGT、ALP、白蛋白（Alb）、胆碱酯酶（CHE）、凝血酶原时间（PT）、凝血酶原活动度（PTA）]和淋巴细胞计数。符合正态分布的计量资料组间比较采用t检验,相关性分析采用Pearson相关分析;不符合正态分布的计量资料组间比较采用Mann-Whitney U检验,相关性分析采用Spearman相关分析。计数资料组间比较采用χ2检验。结果 2组患者的HBs Ag比较差异有统计学意义...
- 肝肿瘤 /
- 肝炎病毒,乙型 /
- 肝肾阴虚 /
- 淋巴细胞计数 /
- 生物因子
Abstract:
Objective To investigate the tumor features and the correlation between lymphocyte count and biochemical parameters in patients with hepatitis B virus- associated primary liver cancer( PLC) with yin deficiency. Methods A total of 148 PLC patients who were treated in Beijing Ditan Hospital,Capital Medical University,from July 2013 to February 2015 were enrolled and divided into yin- deficiency PLC group( 52 patients) and non- yin- deficiency PLC group( 96 patients). The patients' general information and laboratory markers were collected,including oncological parameters( alpha- fetoprotein,carcinoembryonic antigen( CEA),and carbohydrate antigen 199( CA19- 9)),virological parameter( HBs Ag),gross type( nodular type,massive type,bulky type,and diffuse type),radiological features( main portal vein diameter,portal vein tumor thrombus,and extrahepatic metastasis),biochemical parameters( Model for End- Stage Liver Disease( MELD) score,white blood cell,red blood cell,platelet( PLT),alanine aminotransferase,aspartate aminotransferase,total bilirubin( TBil),gamma- glutamyl transpeptidase,alkaline phosphatase,albumin,cholinesterase,prothrombin time( PT),and prothrombin time activity( PTA)),and lymphocyte count. The t- test was applied for comparison of normally distributed continuous data between groups,and the Pearson correlation analysis was applied for correlation analysis. The Mann- Whitney U test was applied for comparison of non- normally distributed continuous data between groups,and the Spearman correlation analysis was applied for correlation analysis. The chi- square test was applied for comparison of categorical data between groups. Results HBs Ag showed a significant difference between the two groups( χ2= 5. 658,P = 0. 017). Compared with the non- yin- deficiency PLC group,the yin- deficiency PLC group had significantly increased CEA and CA19- 9( U =- 2. 200 and- 2. 194,both P < 0. 05),significantly increased MELD score,TBil,and PT( t = 2. 2,U=- 2. 0,U =- 2. 0,all P < 0. 05),and significantly reduced PLT and PTA( U =- 3. 1,t =- 2. 5,both P < 0. 05),as well as significantly reduced lymphocyte,T lymphocyte,CD8+T lymphocyte,and CD4+T lymphocyte( t =- 2. 7,U =- 2. 6,t =- 2. 2,U =- 2. 9,all P < 0. 05). In the PLC patients with yin deficiency,CD4+T lymphocyte count was positively correlated with PLT and PTA( r = 0. 360 and 0. 295,both P < 0. 05); CD8+T lymphocyte count was positively correlated with PLT and PTA( r = 0. 352 and 0. 464,both P < 0. 05)and was negatively correlated with MELD score,TBil,and PT( r =- 0. 358,- 0. 378,and- 0. 520,all P < 0. 05). Conclusion Compared with the liver cancer patients with other syndrome types,PLC patients with yin deficiency have a worse liver synthetic function,more significant cholestatic symptoms,and a lower immune function,and coagulation function tends to become worse when CD4+T lymphocyte count decreases. With the decreasing CD8+T lymphocyte count,coagulation function and liver reserve function become worse.
- liver neoplasms /
- hepatitis B virus /
- liver-kidney yin deficiency /
- lymphocytes count /
- biological factors

HTML全文

参考文献(22)

[1]PARKN DM.The global health burden of infection-associated cancers in the year 2002[J].Int J Cancer,2006,118(12):3030-3044.

[2]TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.

[3]WANG ZS,HOU AM.Analysis on the risk factors of primary hepatic cancer related to viral infections[J].Int J Virol,2015,22(6):399-402.(in Chinese)王智珊,侯安明.病毒感染相关性原发性肝癌患病危险因素分析[J].国际病毒学杂志,2015,22(6):399-402.

[4]WILLIMSKY G,SCHMIDT K,LODDENKEMPER C,et al.Virusinduced hepatocellular carcinomas cause antigen-specific local tolerance[J].J Clin Invest,2013,123(3):1032-1043.

[5]CHEW V,TOW C,TEO M,et al.Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients[J].J Hepatol,2010,52(3):370-379.

[6]NOZAWA H,CHIU C,HANAHAN D.Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis[J].Proc Natl Acad Sci U S A,2006,103(33):12493-12498.

[7]HIRAOKA N,ONOZATO K,KOSUGE T,et al.Prevalence of FOXP3+regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions[J].Clin Cancer Res,2006,12(18):5423-5434.

[8]ZITVOGEL L,TESNIERE A,KROEMER G.Cancer despite immunosurveillance:immunoselection and immunosubversion[J].Nat Rev Immunol,2006,6(10):715-727.

[9]People's Republic of China Ministry of Health.Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.

[10]Bureau of Technical Supervision.The syndromes section of TCM term of clinical diagnosis and treatment[M].Beijing:TCM Standard Publishing House,1997:37-38.(in Chinese)国家技术监督局.中医临床诊疗术语证候部分[M].北京:中医标准出版社,1997:37-38.

[11]XING FJ,LI L,ZHOU ZY.Professor Zhou Zhong-ying's experience on the treatment of liver cancer by complex decoction[J].Jilin J Tradit Chin Med,2014,34(1):22-25.(in Chinese)邢风举,李柳,周仲瑛.周仲瑛教授应用复法大方治疗肝癌[J].吉林中医药,2014,34(1):22-25.

[12]SUN M,CHEN Q.Discussing the relationship between TCM syndrome of primary liver cancer and ultrasonography[J].Hubei J Tradit Chin Med,2011,33(2):20-21.(in Chinese)孙敏,陈群.原发性肝癌中医分型与超声表现关系探讨[J].湖北中医杂志,2011,33(2):20-21.

[13]YAN ZS,WEI QC,ZHANG HY,et al.The study of relationship between clinical characteristic of TCM syndrome of primary liver cancer and prognosis[J].Pract Tradit Chin Intern Med,2006,20(4):411-412.(in Chinese)燕忠生,魏千程,张慧渊,等.原发性肝癌中医证型临床特点与预后关系研究[J].实用中医内科杂志,2006,20(4):411-412.

[14]LIN LZ,LAN SQ.Correlation between TCM syndromes of primary liver cancer and liver function and liver reserve function[J].China Cancer,2000,9(8):347-348.(in Chinese)林丽珠,蓝韶清.肝癌中医证型与肝功能及肝脏储备功能的相关性[J].中国肿瘤,2000,9(8):347-348.

[15]SHEN F,ZHU YQ.Research progress in the syndrome of liver cancer and clinical indexes[J].Chin J Med Guide,2013,15(4):614-615.(in Chinese)沈飞,朱亚青.肝癌辨证分型与临床指标的研究进展[J].中国医药导刊,2013,15(4):614-615.

[16]ALI MY,GRIMM CF,RITTER M,et al.Activation of dendritic cells by local ablation of hepatocellular carcinoma[J].J Hepatol,2005,43(5):817-822.

[17]NAPOLETANO C,TAURINO F,BIFFONI M,et al.RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients[J].Int J Oncol,2008,32(2):481-490.

[18]LIN LZ,LAN SQ.The study of relationship between TCM syndrome of primary liver cancer and immune function[J].Zhejiang J Integr Tradit Chin West Med,2001,11(7):408-410.(in Chinese)林丽珠,蓝韶清.原发性肝癌中医证型与免疫功能关系的研究[J].浙江中西医结合杂志,2001,11(7):408-410.

[19]HARDKE-WOLENSKI M,KRAUS L,SCHMETZ C,et al.Exchange of cytosolic content between T cells and tumor cells activates CD4 T cells and impedes cancer growth[J].PLos One,2013,8(10):1-13.

[20]PAGES F,KIRILOVSKY A,MLECNIK B,et al.In situ cytotoxic and memory T cell predict outcome in patients with early-stage colorectal cancer[J].J Clin Oncol,2009,27(35):5944-5951.

[21]KAWAI O,ISHII G,KUBOTA K,et al.Predominant infiltration of macrophages and CD8(+)T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer[J].Cancer,2008,113(6):1387-1395.

[22]MAHMOUD SM,PAISH EC,POWE DG,et al.Tumor-infiltrating CD8+lymphocytes predict clinical outcome in breast cancer[J].J Clin Oncol,2011,29(15):1949-1955.

施引文献

资源附件(0)

访问统计